z-logo
open-access-imgOpen Access
Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel
Author(s) -
Burçin Yavuz,
Laura Chambre,
Kristin R V Harrington,
Jonathan A. Kluge,
Livio Valenti,
David L. Kaplan
Publication year - 2020
Publication title -
acs applied bio materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.764
H-Index - 17
ISSN - 2576-6422
DOI - 10.1021/acsabm.0c00671
Subject(s) - transdermal , fibroin , levonorgestrel , drug delivery , transdermal patch , biomedical engineering , drug , silk , materials science , nanotechnology , pharmacology , medicine , population , composite material , family planning , environmental health , research methodology
The sustained release of levonorgestrel, a contraceptive, from silk-based microneedle patches was demonstrated for transdermal delivery. Modifications in the formulation of the silk protein and drug loading enabled the tuning of drug loading and release rates from the microneedle patches over time. Sustained drug release reached up to 100 days when the drug was loaded directly inside the microneedles, while release continued for more than a year when the drug was loaded inside microparticles prior to casting inside the microneedle patches. When coupled with the shelf-stable, refrigeration-less features of the silk protein matrix utilized in the microneedle fabrication, these findings suggest that long-acting contraception patches are feasible. This advance could provide practical options for women to have access to new options for protection against unwanted pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom